Evidence map›Paper›PMID 38694406›Full record

ArticleFrontiers in chemistry2024

Acyl pyrazole sulfonamides as new antidiabetic agents: synthesis, glucosidase inhibition studies, and molecular docking analysis.

Atteeque Ahmed, Sumera Zaib, Mashooq Ahmad Bhat, Aamer Saeed, Muhammad Zain Altaf, Fatima Tuz Zahra, Ghulam Shabir, Nehal Rana, Imtiaz Khan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Atteeque AhmedDepartment of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
Sumera ZaibDepartment of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan.
Mashooq Ahmad BhatDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Aamer SaeedDepartment of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
Muhammad Zain AltafDepartment of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan.
Fatima Tuz ZahraDepartment of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
Ghulam ShabirDepartment of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
Nehal RanaDepartment of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan.
Imtiaz KhanDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, United Kingdom.
Quaid-i-Azam University · PKUniversity of Central Punjab · PKKing Saud University · SAUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is a multi-systematic chronic metabolic disorder and life-threatening disease resulting from impaired glucose homeostasis. The inhibition of glucosidase, particularly

Indexed as

alpha glucosidasediabetes mellituspharmacokineticspyrazole-clubbed sulfonamidesSeeSAR

Identifiers

PMID38694406
PMCPMC11061460
OpenAlexW4394888306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.